Contact this trialFirst, we need to learn more about you.
Anti-metabolites
sFOLFOXIRI for Gastroesophageal Cancer
Recruiting1 awardPhase 2
New Brunswick, New Jersey
This trial is testing a new treatment regimen to see if it is effective in terms of objective response rate, progression free survival, and overall survival. They will also be looking at the safety and toxicity profile of the new treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service